DriverDB: an exome sequencing database for cancer driver gene identification
暂无分享,去创建一个
Wei-Chung Cheng | Ting-Yu Chang | Hsei-Wei Wang | I-Fang Chung | Hsing-Jen Sun | Wei-Chun Tang | Chen-Yang Chen | Tai-Tong Wong | Jun-Jeng Fen | Wei-Chung Cheng | Hsei-Wei Wang | T. Wong | Ting-Yu Chang | I-Fang Chung | Hsing-Jen Sun | Jun-Jeng Fen | Wei Tang | Chen-Yang Chen
[1] A. Gonzalez-Perez,et al. Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation , 2012, Genome Medicine.
[2] P. Stenson,et al. The Human Gene Mutation Database (HGMD) and Its Exploitation in the Study of Mutational Mechanisms , 2005, Current protocols in bioinformatics.
[3] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[4] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[5] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[6] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[7] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[8] Michael A. Dyer,et al. Neuroblastoma: developmental biology, cancer genomics and immunotherapy , 2013, Nature Reviews Cancer.
[9] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] Ryo Maekawa,et al. Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine Leiomyomas , 2013, PloS one.
[11] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[12] Tom R. Gaunt,et al. Predicting the functional consequences of cancer-associated amino acid substitutions , 2013, Bioinform..
[13] Johnny S. H. Kwan,et al. Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies , 2013, PLoS genetics.
[14] Frauke Sprengel,et al. BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data , 2013, Bioinform..
[15] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[16] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[17] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[18] Sergey I. Nikolenko,et al. BayesHammer: Bayesian clustering for error correction in single-cell sequencing , 2012, BMC Genomics.
[19] Eli Upfal,et al. Finding driver pathways in cancer: models and algorithms , 2011, Algorithms for Molecular Biology.
[20] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[21] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[22] Justin C. Fay,et al. Identification of deleterious mutations within three human genomes. , 2009, Genome research.
[23] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[24] G. Hong,et al. Nucleic Acids Research , 2015, Nucleic Acids Research.
[25] Nuria Lopez-Bigas,et al. IntOGen: integration and data mining of multidimensional oncogenomic data , 2010, Nature Methods.
[26] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[27] Gary D Bader,et al. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .
[28] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[29] M. Stratton,et al. The cancer genome , 2009, Nature.
[30] Ian M. Donaldson,et al. iRefIndex: A consolidated protein interaction database with provenance , 2008, BMC Bioinformatics.
[31] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[32] F. Gnad,et al. Assessment of computational methods for predicting the effects of missense mutations in human cancers , 2013, BMC Genomics.
[33] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[34] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .
[35] Jacob A. Tennessen,et al. Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes , 2012, Science.
[36] Tyson A. Clark,et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array , 2006, BMC Genomics.
[37] Paul S Mischel,et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. , 2012, Cancer discovery.
[38] F. Collins,et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.
[39] Hongmin Li,et al. A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers , 2008, PLoS Genetics.
[40] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[41] Roded Sharan,et al. Simultaneous Identification of Multiple Driver Pathways in Cancer , 2013, PLoS Comput. Biol..
[42] Christie S. Chang,et al. The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..
[43] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[44] Steven J. M. Jones,et al. The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.
[45] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[46] Gary D. Bader,et al. Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..
[47] Rafael C. Jimenez,et al. The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..
[48] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[49] Qi Liu,et al. Next generation sequencing in cancer research and clinical application , 2013, Biological Procedures Online.
[50] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[51] Eli Upfal,et al. De Novo Discovery of Mutated Driver Pathways in Cancer , 2011, RECOMB.
[52] Lilia M. Iakoucheva,et al. Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation , 2012, Cell.
[53] Raul Rabadan,et al. MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples , 2013, BMC Systems Biology.
[54] Richard Simon,et al. Identifying cancer driver genes in tumor genome sequencing studies , 2011, Bioinform..
[55] Shi-Hua Zhang,et al. Efficient methods for identifying mutated driver pathways in cancer , 2012, Bioinform..
[56] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[57] Ute Hamann,et al. Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan , 2013, BMC Cancer.
[58] D. Small,et al. FLT3 mutations: biology and treatment. , 2006, Hematology. American Society of Hematology. Education Program.
[59] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[60] C. Sander,et al. Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.
[61] M. Kimmel,et al. Conflict of interest statement. None declared. , 2010 .
[62] C. Yeo,et al. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. , 2011, Surgery.
[63] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[64] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[65] Christopher A. Miller,et al. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors , 2011, BMC Medical Genomics.
[66] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[67] Yuedong Yang,et al. DDIG-in: discriminating between disease-associated and neutral non-frameshifting micro-indels , 2013, Genome Biology.